Log In
    News

    C-Suite Interview with Baudax Bio (BXRX) President & CEO Gerri Henwood

    3/1/2022
    Health
    0 min read

    Noble Capital Markets Senior Research Analyst Gregory Aurand sits down with Baudax Bio President & CEO Gerri Henwood for this exclusive interview.

    Research, News, and Advanced Market Data on BXRX


    View all C-Suite Interviews


    The 2022 C-Suite Interview series is now available on major podcast platforms

    About Baudax Bio

    Baudax Bio is a pharmaceutical company focused on commercializing and developing innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.

    Share
    Related News
    ‌
    Probe Gold Expands its Monique Gold Deposit with Key Acquisition
    12/20/2024
    Natural Resources

    Probe Gold Expands its Monique Gold Deposit with Key Acquisition

    Probe Gold Inc. has announced the acquisition of the Bermont Claims property, strategically located adjacent to its Monique Gold Deposit in Val-d’Or, Quebec. This move is poised to extend the...
    3 min read
    ‌
    Release – LODE: Comstock Sells Northern Mining Targets to Mackay Precious Metals
    12/20/2024
    Basic Materials

    Release – LODE: Comstock Sells Northern Mining Targets to Mackay Precious Metals

    Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced it has executed a Membership Interest Purchase Agreement (the “MIPA”) to sell 100% of the northernmost patented and unpatented mining...
    7 min read
    ‌
    Steelcase (SCS) – Reports Third Quarter Results
    12/20/2024
    Industrials

    Steelcase (SCS) – Reports Third Quarter Results

    3Q25 Results. Revenue was $794.9 million, up 2.1% y-o-y, with higher revenue from government, large corporate, healthcare, and education customers as the drivers. Organic revenue was up 3%, with Americas up...
    2 min read
    ‌
    Great Lakes Dredge & Dock (GLDD) – $182 Million of Awarded Work
    12/20/2024
    Industrials

    Great Lakes Dredge & Dock (GLDD) – $182 Million of Awarded Work

    Awarded Work. Great Lakes announced an additional $182 million of awarded work across four projects. The new projects were part of the $465 million of low bids and options pending as...
    3 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In